Etanercept, childhood and long-term safety: a case of five years treatment

Eur J Dermatol. 2011 Sep-Oct;21(5):776-7. doi: 10.1684/ejd.2011.1432.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis, Psoriatic / drug therapy
  • Child
  • Etanercept
  • Humans
  • Immunoglobulin G / administration & dosage*
  • Immunoglobulin G / therapeutic use
  • Male
  • Pain Measurement
  • Psoriasis / drug therapy*
  • Receptors, Tumor Necrosis Factor / administration & dosage*
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Recurrence

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept